Krafte Douglas 4
4 · Icagen, Inc. · Filed Nov 16, 2018
Insider Transaction Report
Form 4
Icagen, Inc.NONE
Krafte Douglas
Chief Scientific Officer
Transactions
- Award
Stock Option
2018-11-14+120,000→ 120,000 totalExercise: $3.50From: 2018-11-14Exp: 2028-11-14→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option vest on pro rata on a monthly basis over three years commencing on November 30, 2018.